Mental Health and Behavioral Changes Some patients report: Depression Mood changes Suicidal thoughts While not yet proven as a direct effect, the FDA advises close monitoring of mental health while on GLP-1 drugs
Too often, he says, GLP-1 users eat less, but also eat poorly
These medications can be continued, along with your Metformin, to improve your health, with no set end time
The semaglutide segment dominates the market with a share of 71% due to its proven efficacy in controlling blood glucose and promoting weight loss
Risks to Patients with Serious Cardiac Disease Advise patients that there are potential risks to patients with serious cardiac disease, including sudden death, with VYVANSE use
The duration guide for semaglutide addresses this question in detail